Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - Other
Ratios

Bristol Myers Squibb (BMYMP) Other Gross PP&E Adjustments (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Other Gross PP&E Adjustments for 17 consecutive years, with -$1.4 billion as the latest value for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments fell 34.05% to -$1.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.4 billion through Dec 2025, down 34.05% year-over-year, with the annual reading at -$1.4 billion for FY2025, 34.05% down from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was -$1.4 billion at Bristol Myers Squibb, up from -$1.4 billion in the prior quarter.
  • The five-year high for Other Gross PP&E Adjustments was -$678.0 million in Q2 2022, with the low at -$1.4 billion in Q3 2025.
  • Average Other Gross PP&E Adjustments over 5 years is -$1.0 billion, with a median of -$1.1 billion recorded in 2023.
  • The sharpest move saw Other Gross PP&E Adjustments rose 19.0% in 2022, then crashed 67.13% in 2023.
  • Over 5 years, Other Gross PP&E Adjustments stood at -$750.0 million in 2021, then plummeted by 41.07% to -$1.1 billion in 2022, then fell by 16.07% to -$1.2 billion in 2023, then grew by 13.44% to -$1.1 billion in 2024, then plummeted by 34.05% to -$1.4 billion in 2025.
  • According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at -$1.4 billion, -$1.4 billion, and -$1.1 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.